Calliditas Therapeutics AB (publ) announced the appointment of Jonathan Schur as Group General Counsel, effective October 1, 2020. Jonathan Schur has over 30 years of experience as a lawyer and is a member of the New York and Paris Bars. Prior to joining Calliditas, Mr. Schur was a Partner in the Life Sciences team at Goodwin Procter LLP, and before that a partner and co-managing partner of the Paris Office of Dechert LLP.